Aytu Biopharma (AYTU) Capital Expenditures (QoQ) (2016 - 2025)
Aytu Biopharma (AYTU) Capital Expenditures (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Aytu Biopharma | 24.60 Mn | -2.12 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -75.36% |
| Mar 31, 2025 | 1,050.00% |
| Dec 31, 2024 | -95.59% |
| Sep 30, 2024 | -58.66% |
| Jun 30, 2020 | -533.33% |
| Mar 31, 2020 | -70.00% |
| Jun 30, 2019 | 159.47% |
| Mar 31, 2019 | -193.23% |
| Dec 31, 2018 | 12,990.44% |
| Mar 31, 2017 | 254.93% |
| Dec 31, 2016 | -191.02% |
| Sep 30, 2016 | -40.22% |
| Jun 30, 2016 | 348.62% |
| Mar 31, 2016 | -162.30% |